Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             108 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests Belozertseva, I.V.
 2007
 17 Supplement 3 p. 172-179
8 p.
 artikel
2 Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive–compulsive disorder: A meta-analysis of the randomized controlled trials Skapinakis, Petros
 2007
 17 Supplement 3 p. 79-93
15 p.
 artikel
3 A significant correlation between ward temperature and the severity of symptoms in schizophrenia inpatients — A longitudinal study Shiloh, Roni
 2007
 17 Supplement 3 p. 478-482
5 p.
 artikel
4 Author Index 2007
 17 Supplement 3 p. S169-S170
2 p.
 artikel
5 C.15.03 Bipolar disorder: optimal management strategies Bowden, C.L.
 2007
 17 Supplement 3 p. S607-S608
2 p.
 artikel
6 C.02.03 Challenges in treating to remission: current practice versus clinical evidence Burrows, G.
 2007
 17 Supplement 3 p. S597-
1 p.
 artikel
7 C.06.04 Cognitive improvement and its effects on daily life function Davidson, M.
 2007
 17 Supplement 3 p. S602-
1 p.
 artikel
8 C.09.03 How existing treatments have helped patients and their current limitations – safety Buckley, P.
 2007
 17 Supplement 3 p. S603-
1 p.
 artikel
9 C.21.02 Long-term treatment with atypical antipsychotics: establishing a balance between efficacy and tolerability Heald, A.H.
 2007
 17 Supplement 3 p. S612-
1 p.
 artikel
10 CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence Sher, Leo
 2007
 17 Supplement 3 p. 12-15
4 p.
 artikel
11 Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cells Tan, Qing-Rong
 2007
 17 Supplement 3 p. 768-773
6 p.
 artikel
12 Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression Kluge, Michael
 2007
 17 Supplement 3 p. 527-531
5 p.
 artikel
13 E.06.01 Effects of drugs on the fetus Jacqz-Aigrain, E.
 2007
 17 Supplement 3 p. S224-
1 p.
 artikel
14 Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells—A possible interaction with psychotropic drugs Basta-Kaim, Agnieszka
 2007
 17 Supplement 3 p. 37-45
9 p.
 artikel
15 Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: A microdialysis study Hu, Xiao Jing
 2007
 17 Supplement 3 p. 580-586
7 p.
 artikel
16 Effects of the novel 5-HT6 receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating Schreiber, Rudy
 2007
 17 Supplement 3 p. 277-288
12 p.
 artikel
17 How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes Artioli, Paola
 2007
 17 Supplement 3 p. 587-594
8 p.
 artikel
18 Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression Taler, Michal
 2007
 17 Supplement 3 p. 774-780
7 p.
 artikel
19 Keyword Index 2007
 17 Supplement 3 p. S631-S637
7 p.
 artikel
20 Membrane fatty acids, reading and spelling in dyslexic and non-dyslexic adults Cyhlarova, Eva
 2007
 17 Supplement 3 p. 116-121
6 p.
 artikel
21 ME1 Treatment-resistant depression Nolen, W.A.
 2007
 17 Supplement 3 p. S145-
1 p.
 artikel
22 Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial Wozniak, Janet
 2007
 17 Supplement 3 p. 440-447
8 p.
 artikel
23 P.8.a.014 Absence of circadian and seasonal rhythms of total antioxidant status in healthy subjects Morera, A.
 2007
 17 Supplement 3 p. S587-S588
2 p.
 artikel
24 P.1.a.011 Association of monoamine oxidase A gene and clinical subgroups of major depressive disorders in the Han Chinese Huang, H.S.Y.
 2007
 17 Supplement 3 p. S233-
1 p.
 artikel
25 P.2.a.019 Association study of the 5-HTT polymorphism and mirtazapine antidepressant response in major depressive disorder Kang, R.H.
 2007
 17 Supplement 3 p. S322-S323
2 p.
 artikel
26 P.1.a.008 Catechol-O-methyltrasferase gene polymorphism (Val/Met) is not associated with bipolar disorder Chee, I.S.
 2007
 17 Supplement 3 p. S231-S232
2 p.
 artikel
27 P.1.42 Activation of glucocorticoid receptors in the hippocampus is dependent upon the pattern of glucocorticoid presentation Conway-Campbell, B.L.
 2007
 17 Supplement 3 p. S36-S37
2 p.
 artikel
28 P.3.a.024 Elaboration of immigration and risk for non affective psychotic disorders Werbeloff, N.
 2007
 17 Supplement 3 p. S414-S415
2 p.
 artikel
29 P.2.008 Antidepressant-like effect of SKF-38393 administered in combination with dehydroepiandrosterone in gonadectomized male rats Fedotova, J.
 2007
 17 Supplement 3 p. S158-S159
2 p.
 artikel
30 P.5.a.002 Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients Pawelczyk, T.
 2007
 17 Supplement 3 p. S526-S527
2 p.
 artikel
31 P.3.a.021 Physical capacity and energy expenditure during exercise in patients with schizophrenia and healthy controls Nilsson, B.M.
 2007
 17 Supplement 3 p. S413-
1 p.
 artikel
32 P.2.a.002 Plasma BDNF as a peripheral marker for the action mechanism of antidepressants Kim, Y.K.
 2007
 17 Supplement 3 p. S312-S313
2 p.
 artikel
33 P.2.a.016 Prevalence and clinical correlates of pain in patients with recurrent major depressive disorder Ahmed, S.
 2007
 17 Supplement 3 p. S320-S321
2 p.
 artikel
34 P.4.a.005 Rapid onset anxiolitic efficacy after a single dose of pregabalin: evaluation using dental anxiety model Nutt, D.J.
 2007
 17 Supplement 3 p. S503-
1 p.
 artikel
35 P.3.a.007 Schizophrenia with depressive symptoms and treatment possibilities Purvina, S.
 2007
 17 Supplement 3 p. S405-
1 p.
 artikel
36 P.1.08 Associations between plasma BDNF and CCK-4 challenge in healthy subjects Maron, E.
 2007
 17 Supplement 3 p. S8-S9
2 p.
 artikel
37 P.3.12 Association study of GSK-3β −50T/C polymorphism with executive performances in schizophrenia Poletti, S.
 2007
 17 Supplement 3 p. S79-
1 p.
 artikel
38 P.3.10 Association study of GSK-3β −50T/C polymorphism with haloperidol resistance in schizophrenia Bosia, M.
 2007
 17 Supplement 3 p. S77-S78
2 p.
 artikel
39 P.8.a.017 The effects of modafinil on driving and self-assessment of driving performance during sleep deprivation Gurtman, C.
 2007
 17 Supplement 3 p. S589-S590
2 p.
 artikel
40 P.6.a.012 Trazodone treatment in the sleep disturbances of alcohol-dependent patients after detoxification Ciobanu, A.
 2007
 17 Supplement 3 p. S545-
1 p.
 artikel
41 P.2.a.033 Treatment resistant depression: prednisolone suppression test predicts response to inpatient treatment Juruena, M.F.
 2007
 17 Supplement 3 p. S330-S331
2 p.
 artikel
42 P.4.b.006 Clinical profiles of obsessive compulsive symptoms in schizophrenic patients Koo, M.
 2007
 17 Supplement 3 p. S513-
1 p.
 artikel
43 P.4.b.003 Effect of GABAergic ligands on the anxiolytic-like activity of antidepressants in the four-plates test in mice Bourin, M.
 2007
 17 Supplement 3 p. S511-
1 p.
 artikel
44 P.2.b.015 Gender and the dexamethasone suppression test threshold in suicide prediction Jokinen, J.
 2007
 17 Supplement 3 p. S340-S341
2 p.
 artikel
45 P.3.b.010 Insulin-like growth factor 1 and recent onset schizophrenia Huizer, K.
 2007
 17 Supplement 3 p. S423-
1 p.
 artikel
46 P.2.12 Blockade of 5-HT2C receptors, possibly in the orbital cortex, decreases compulsive lever-pressing in rats Flaisher, S.
 2007
 17 Supplement 3 p. S49-
1 p.
 artikel
47 P.1.b.004 Neural basis of acquired psychomotor resistance deficiency syndrome against to stress induced by toxic levels of noise Aydin, N.
 2007
 17 Supplement 3 p. S242-
1 p.
 artikel
48 P.2.b.012 Plasma cortisol levels and resilience in depressed patients Camardese, G.
 2007
 17 Supplement 3 p. S338-S339
2 p.
 artikel
49 P.3.c.061 A review of liver function tests during treatment with a typical antipsychotic drugs: a chart review study Atasoy, N.
 2007
 17 Supplement 3 p. S459-S460
2 p.
 artikel
50 P.5.c.001 Clinical correlates of psychiatric adverse events of anticonvulsant drugs in patients with epilepsy Mula, M.
 2007
 17 Supplement 3 p. S535-
1 p.
 artikel
51 P.1.c.045 Effect of denervation of the locus coeruleus on cocaine induced locomotion and cocaine conditioned place preference Koĩv, K.
 2007
 17 Supplement 3 p. S268-
1 p.
 artikel
52 P.1.25 Chronic antidepressant treatments induces specific changes in BDNF expression and subcellular localization Maj, P.F.
 2007
 17 Supplement 3 p. S22-S23
2 p.
 artikel
53 P.1.c.048 5-HT7 receptors interact with NMDA and 5-HT1A receptor-dependent emotional learning and exploratory activity in mice Eriksson, T.M.
 2007
 17 Supplement 3 p. S270-
1 p.
 artikel
54 P.2.c.024 Impact of polymorphism of cytochrome P450 2D6 on clinical effects of mirtazapine Kim, J.
 2007
 17 Supplement 3 p. S354-
1 p.
 artikel
55 P.3.c.071 Is switching to aripiprazole an option in overweight patients? A 12 months naturalistic follow-up study Schorr, S.G.
 2007
 17 Supplement 3 p. S465-
1 p.
 artikel
56 P.1.c.017 Morphine-induced locomotor sensitization increases FADD phosphorylation in rat brain Ramos-Miguel, A.
 2007
 17 Supplement 3 p. S251-S252
2 p.
 artikel
57 P.1.003 Comparative study of the effects of tacrine, donepezil and rivastigmine in rats with diazepam-induced amnesia Dimitrova, D.
 2007
 17 Supplement 3 p. S148-S149
2 p.
 artikel
58 P.3.c.047 Pharmacokinetics of RGH-188, a new dopamine D3/D2 antagonist/partial agonist atypical antipsychotic, in healthy subjects P´asztor M´esz´aros, G.
 2007
 17 Supplement 3 p. S451-S452
2 p.
 artikel
59 P.3.c.033 Prolactin levels and side effects of long-acting risperidone injection and oral treatments in psychotic disorders Szerman, N.
 2007
 17 Supplement 3 p. S443-
1 p.
 artikel
60 P.3.c.030 Psychiatrists' attitudes to antipsychotic depots II: changes over the past 5 years Patel, M.X.
 2007
 17 Supplement 3 p. S441-S442
2 p.
 artikel
61 P.2.c.010 Quetiapine augmentation in depressed patients with partial or no response to antidepressants Olver, J.S.
 2007
 17 Supplement 3 p. S346-S347
2 p.
 artikel
62 P.4.c.004 Relevance of anxiety in emergencies Gines, J.
 2007
 17 Supplement 3 p. S518-S519
2 p.
 artikel
63 P.1.c.031 Role of CB1 receptors in the basolateral amygdala in conditioned aversion, associated analgesia and neuronal activation Roche, M.
 2007
 17 Supplement 3 p. S259-S260
2 p.
 artikel
64 P.1.c.014 The influence of prenatal administration of arginine-vasopressin on the postpound behaviour in white rats Voskresenskaya, O.
 2007
 17 Supplement 3 p. S249-S250
2 p.
 artikel
65 P.3.c.016 The relation between insulin receptor substrate-1 gene and olanzapine-induced weight gain and smoking in schizophrenia patients Sengul, C.
 2007
 17 Supplement 3 p. S433-
1 p.
 artikel
66 P.7.c.004 Valproate in the treatment of acute mania in adolescents with bipolar disorder Azorin, J.M.
 2007
 17 Supplement 3 p. S573-S574
2 p.
 artikel
67 P.3.c.074 Weight gain associated with olanzapine and first generation antipsychotics: results from a pragmatic randomized controlled trial Silva de Lima, M.
 2007
 17 Supplement 3 p. S467-
1 p.
 artikel
68 P.3.d.021 Differential gene expressions in frontal cortex of rats induced by chronic release of risperidone Kim, K.
 2007
 17 Supplement 3 p. S485-
1 p.
 artikel
69 P.2.d.021 Distinct electrophysiological effects of citalopram and escitalopram on mesolimbic dopamine neuronal activity in rats Dremencov, E.
 2007
 17 Supplement 3 p. S373-S374
2 p.
 artikel
70 P.2.d.018 Effects from vagus nerve stimulation on rat hippocampal progenitor proliferation Revesz, D.
 2007
 17 Supplement 3 p. S371-S372
2 p.
 artikel
71 P.1.d.009 Effects of Serotonin 2C and GABA A receptor ligands in brain stimulation reward and locomotor activity Hayes, D.J.
 2007
 17 Supplement 3 p. S278-
1 p.
 artikel
72 P.5.d.002 Increased levels of kynurenic acid may account for neuropsychiatric symptoms in patients with tick-borne encephalitis Schwieler, L.
 2007
 17 Supplement 3 p. S536-S537
2 p.
 artikel
73 P.6.d.004 Regulation of the apoptotic machinery in the prefrontal cortex of human opioid abusers García-Sevilla, J.A.
 2007
 17 Supplement 3 p. S553-S554
2 p.
 artikel
74 P.2.d.004 Role of adenosine and adenosine A2A receptors in the antidepressant effect of amitriptyline Sezer, G.
 2007
 17 Supplement 3 p. S364-
1 p.
 artikel
75 P.3.d.004 Sensorimotor gating of the acoustic startle response is improved by morphine in healthy human volunteers Quednow, B.B.
 2007
 17 Supplement 3 p. S475-S476
2 p.
 artikel
76 P.3.d.018 The effects of the antipsychotic drugs on collagen-induced platelet aggregation in vitro Dietrich-Muszalska, A.
 2007
 17 Supplement 3 p. S483-S484
2 p.
 artikel
77 P.6.d.007 The selective nicotinic alpha7 receptor agonist SSR180711 does not induce locomotor sensitisation Mirza, N.
 2007
 17 Supplement 3 p. S555-S556
2 p.
 artikel
78 P.3.e.012 Cabergoline treatment of amisulpride-induced hyperprolactinemia Di Sciascio, G.
 2007
 17 Supplement 3 p. S493-S494
2 p.
 artikel
79 P.1.e.023 Compensatory prefrontal activation during planning in major depressive disorder; an event related fMRI study van der Wee, N.
 2007
 17 Supplement 3 p. S294-
1 p.
 artikel
80 P.2.e.009 Evaluation of first fifty patients in a bipolar disorder outpatient unit in Turkey: a cross sectional study Ozpoyraz, N.
 2007
 17 Supplement 3 p. S381-
1 p.
 artikel
81 P.7.e.004 Prefrontal cortex N-acetyl-aspartate in early-onset psychosis: cognitive correlates, course and predictive value Zabala, A.
 2007
 17 Supplement 3 p. S579-S580
2 p.
 artikel
82 P.3.e.009 Visual 3 stimulus event-related potential P3a and P3b in passive paradigm in admitted patients with schizophrenia Jeon, Y.W.
 2007
 17 Supplement 3 p. S491-S492
2 p.
 artikel
83 P.6.e.010 Who are incoming cocaine consuming patients in a drug addiction centre in Milan in 2006? Zita, G.
 2007
 17 Supplement 3 p. S563-S564
2 p.
 artikel
84 P.2.f.003 Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state Ventriglia, M.
 2007
 17 Supplement 3 p. S389-S390
2 p.
 artikel
85 P.2.f.006 Quetiapine use in the acute and maintenance phases of bipolar disorder treatment Waheed, W.
 2007
 17 Supplement 3 p. S391-
1 p.
 artikel
86 P.1.g.001 Hypothalamic hamartoma and psychiatry Verhoeven, W.M.A.
 2007
 17 Supplement 3 p. S302-S303
2 p.
 artikel
87 P.1.g.004 Smoking influences global DNA methylation Hillemacher, T.
 2007
 17 Supplement 3 p. S304-S305
2 p.
 artikel
88 P.2.h.003 Depressant-like behavior of TNF-alpha in mice Gadotti, V.M.
 2007
 17 Supplement 3 p. S399-
1 p.
 artikel
89 P.1.03 How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes Marino, E.
 2007
 17 Supplement 3 p. S4-S5
2 p.
 artikel
90 P.2.29 Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions Tamburella, A.
 2007
 17 Supplement 3 p. S62-S63
2 p.
 artikel
91 P.3.07 Is it possible to identify future patients in the months before the first psychotic episode? A population-based study Livny-Ezer, A.
 2007
 17 Supplement 3 p. S74-S75
2 p.
 artikel
92 P.1.11 Is the serotonin transporter gene a predictor for longevity? Pirovano, A.
 2007
 17 Supplement 3 p. S11-
1 p.
 artikel
93 P.2.15 Reduced anxiety and stress responses in mice lacking fatty acid amide hydrolase, an endocannabinoid-degrading enzyme Moreira, F.A.
 2007
 17 Supplement 3 p. S51-
1 p.
 artikel
94 P.3.20 The effect of a low dose of diazepam on emotional processing in healthy volunteers Murphy, S.E.
 2007
 17 Supplement 3 p. S85-S86
2 p.
 artikel
95 S.06.03 Cognitive dysfunctions and dementia in Parkinson's disease Janvin, C.
 2007
 17 Supplement 3 p. S184-
1 p.
 artikel
96 S.10.05 European guidelines: long-term safety of medication Zuddas, A.
 2007
 17 Supplement 3 p. S193-
1 p.
 artikel
97 S.02.05 European research programme on treatment resistant depression Mendlewicz, J.
 2007
 17 Supplement 3 p. S178-
1 p.
 artikel
98 S.19.03 Exploring the early pathogenesis in Alzheimer's disease: insights from transgenic mouse models Meyer-Lühmann, M.
 2007
 17 Supplement 3 p. S205-
1 p.
 artikel
99 S.27.05 Genetic contributions to human brain morphology and intelligence Hulshoff Pol, H.E.
 2007
 17 Supplement 3 p. S217-
1 p.
 artikel
100 S.07.08 Localized gray matter deficits in adolescents with first-episode psychosis Janssen, J.
 2007
 17 Supplement 3 p. S188-
1 p.
 artikel
101 S.03.04 Multimodal neuroimaging of the hippocampal formation in schizophrenia Meyer-Lindenberg, A.
 2007
 17 Supplement 3 p. S179-
1 p.
 artikel
102 S.23.02 Neuropsychological deficits in vascular brain disease van Zandvoort, M.
 2007
 17 Supplement 3 p. S211-
1 p.
 artikel
103 S.16.03 Nicotinic modulation of dopaminergic neurons: upstream and downstream targets of nicotine addiction Mansvelder, H.D.
 2007
 17 Supplement 3 p. S199-S200
2 p.
 artikel
104 S.11.03 Stress responses in anxiety disorders Young, E.
 2007
 17 Supplement 3 p. S194-
1 p.
 artikel
105 State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients Ritsner, Michael
 2007
 17 Supplement 3 p. 257-264
8 p.
 artikel
106 S.20.01 The central galanin system – an overview Hökfelt, T.
 2007
 17 Supplement 3 p. S206-
1 p.
 artikel
107 Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats Nishikawa, Hiroyuki
 2007
 17 Supplement 3 p. 643-650
8 p.
 artikel
108 Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results Haro, Josep Maria
 2007
 17 Supplement 3 p. 235-244
10 p.
 artikel
                             108 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland